A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes

Clinical trial NCT05691712 · COMPLETED

Trial details

NCT number: NCT05691712
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Type 2 Diabetes Mellitus Glucose Metabolism Disorders Metabolic Disease Endocrine System Diseases

Start date: 2023-02-05
Primary completion: 2024-07-01
Enrollment: 257

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.